UCLA Journal of Radiation Oncology January 1, 2022 - Flipbook - Page 9
UCLA RADIATION ONCOLOGY JOURNAL
"Once employed to treat Hodgkin’s disease, "total lymphoid
irradation" is now used primarily to minimize the need for
post-transplant immunosuppressive drugs."
Ann Raldow, M.D., MPH
Dept. of Radiation Oncology
9